Focus on Leukemia
Helping Survivors Thrive after Marrow and Cord Blood Transplants
by Elizabeth A. Murphy, EdD, RN
Advances in transplant science have improved outcomes and have made transplant a viable treatment option for more people and a wider range of diseases.
FDA Approves New Treatment for CLL
The FDA has granted accelerated approval for GlaxoSmithKline and Genmab’s Arzerra™ (ofatumumab) for people with chronic lymphocytic leukemia whose cancer is no longer being controlled by other forms of chemotherapy.
Leukemia & Lymphoma Society Fighting Blood Cancers
by Peter West
More than 138,000 Americans will be diagnosed with leukemia, lymphoma, and myeloma this year. For many, a trusted source of information and support will be The Leukemia & Lymphoma Society.
